Global Pneumococcal Vaccine Market
Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
September 06, 2024 07:17 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Product (Prevnar 13, VAXNEUVANCE, PNEUMOSIL), End-use...
22157.jpg
2024 Market Research: Vaccines Market Projected to Reach USD 116.63 Billion by 2027 - Rising Disease Prevalence and Prophylactic Applications Fueling Growth
September 06, 2024 05:57 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Vaccine Adjuvants Market
Vaccine Adjuvants Strategic Research Report 2024
September 05, 2024 04:05 ET | Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
Global Cholera Vaccines Market
Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030
August 30, 2024 04:05 ET | Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
Dengue Vaccine Market
Dengue Vaccine Research Report 2024 with Focus on 40+ Players Including Biological E, GSK, Instituto Butantan, Panacea Biotec, Sanofi, Takeda, Vabiotech - Market Forecast to 2030
August 28, 2024 11:07 ET | Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dengue Vaccine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Dengue Vaccine was...
Global H1N1 Vaccines Market
H1N1 Vaccines Strategic Research Report 2024: Increasing Influenza Outbreaks and Viral Mutations Accelerates Demand - Global Market Forecast to 2030
August 28, 2024 04:27 ET | Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for H1N1 Vaccines is...
Global Dog Vaccine Market
Dog Vaccine Market Research 2024 - Global $2+ Billion Industry Trends, Opportunities & Forecasts, 2019-2029F
August 28, 2024 04:19 ET | Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Global Aquaculture Vaccines Market
Aquaculture Vaccines Market Research 2024 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2029F
August 28, 2024 04:18 ET | Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
22157.jpg
Vaccine Contract Manufacturing Industry Report 2024-2035: The Advent of Virus-like Particles (VLPs)
August 20, 2024 12:16 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others),...
Logo.PNG
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024 19:20 ET | HilleVax, Inc.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine...